Funded Medical Equipment Manufacturing Startups in United States
Recent funding for medical equipment manufacturing (11 rows, dated 2022-11-01 through 2025-05-01) clusters into two bursts: May–March 2025 and late 2022.
Recent funding for medical equipment manufacturing (11 rows, dated 2022-11-01 through 2025-05-01) clusters into two bursts: May–March 2025 and late 2022. In the newest window, Openwater closed on 2024-08-22 with a $54M round and Presidio Medical followed on 2023-06-26 with $72M, but the disclosed “upper tier” is concentrated—only two disclosed amounts exceed $50M ($72M on 2023-06-26 and $54M on 2024-08-22), while the remaining disclosed amounts sit below that range (e.g., Tetrous $7M on 2025-03-10; Galen Robotics $15M on 2022-11-01; Provisio Medical $1M on 2025-05-01). A single outlier stands out on the low end: Provisio Medical’s $1M (2025-05-01) is the smallest disclosed amount shown.
Most recent rounds
11 shownRelated listings
Frequently asked
What’s the largest disclosed round in this medical equipment manufacturing list, and how much larger is it than the next disclosed amounts?
Presidio Medical’s $72M round (Series C, 2023-06-26) is the largest disclosed amount shown. The next-highest disclosed rounds are Openwater at $54M (2024-08-22) and then Galen Robotics at $15M (2022-11-01), making the top two materially above the rest.
Do rounds concentrate in a tight recent time window or are they spread out?
They’re spread across 2022-11-01 to 2025-05-01, but there are noticeable clusters: three rounds land in early November 2022 (Embolx $2M on 2022-11-01; Neochord Inc $3M on 2022-11-14; Galen Robotics $15M on 2022-11-01 among others around that date window), and multiple entries fall between 2023 and 2024 (e.g., Presidio Medical $72M on 2023-06-26, UNandUP $3M on 2023-07-17, Openwater $54M on 2024-08-22).
Which cities appear repeatedly, suggesting local concentration?
Several cities recur within the list: St Louis, Missouri appears twice (CERV, 2025-04-23, undisclosed; UNandUP, 2023-07-17, $3M). California also shows repeated presence across companies in San Francisco (Openwater, 2024-08-22, $54M), Sunnyvale (Embolx, 2022-11-01, $2M), and San Diego (Provisio Medical, 2025-05-01, $1M), though not as a single repeated city.
What does the stage mix look like—how much of the list is ‘Series Unknown’ or undisclosed versus labeled rounds?
Out of 11 rows, 5 are labeled ‘Series Unknown’ or undisclosed (CERV is undisclosed on 2025-04-23; Biocoat is undisclosed on 2022-11-02; Ka Imaging is undisclosed on 2022-11-02; Provisio Medical is ‘Series Unknown’ on 2025-05-01; Openwater is ‘Series Unknown’ on 2024-08-22). Labeled rounds shown include Series A (Tetrous $7M on 2025-03-10; Galen Robotics $15M on 2022-11-01) and Series C (Presidio Medical $72M on 2023-06-26), with one Pre-Seed entry (CERV).
Are there any high-signal outliers beyond the largest round—especially on the low end?
Yes. Provisio Medical’s $1M round (2025-05-01, Series Unknown) is the smallest disclosed amount shown, and it’s far below other disclosed figures like Biocoat/Ka Imaging (both undisclosed on 2022-11-02) and the next-smallest disclosed amount outside the undisclosed cases, such as Embolx at $2M (2022-11-01).
Which entries closed in the most recent 90 days of the data shown, and what are the disclosed amounts in that set?
The most recent date in the rows is 2025-05-01 (Provisio Medical, $1M), and entries within the prior ~90 days include CERV on 2025-04-23 (undisclosed) and Tetrous on 2025-03-10 ($7M). That means the newest disclosed amounts in this window are $1M and $7M, with one undisclosed round (CERV).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.